Sexually transmitted infections

Gepotidacin becomes the first new oral antibiotic for gonorrhea in over 30 years, offering hope for effective treatment options.

Merck reveals promising phase 3 results for DOR/ISL, showing minimal impact on weight and lipids in adults with suppressed HIV-1.

Your daily dose of the clinical news you may have missed.

New data show more than one-third of US adults are unaware of HPV or the HPV vaccine, with gaps greatest in the Midwest and South, where HPV-related cancers are most common.

FDA accepts priority review of gepotidacin for uncomplicated urogenital gonorrhea, with phase 3 data showing non-inferiority to standard injectable therapy.

New findings showcase the transformative impact of long-acting injectable therapies for effective HIV treatment and prevention.

Your daily dose of the clinical news you may have missed.

Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Your daily dose of the clinical news you may have missed.

The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.

New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.

The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.

CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.

These test panels allow clinicians to diagnose multiple STIs from a single specimen, with results available in about 20 minutes.

Your daily dose of the clinical news you may have missed.

Comments on the draft recommendation can be submitted through December 23, 2024.

The CDC just released its annual STD surveillance report. Are you caught up on the latest trends? Try your hand at these 7 questions to find out.

More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.

The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.

Details on educational gaps, vaccination rates, and the importance of an open dialogue between patients and clinicians, here.

Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.

Your daily dose of the clinical news you may have missed.

Parent's stigmatizing beliefs about the HPV vaccine may keep them from communicating openly with teens' clinicians, creating barriers to getting shots in arms.

Vaccine side effects are usually trouble when they make the news. But sometimes, an unexpected result has merit. Find out more.

Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.